CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
Holding CHJTF?
Track your performance easily

CSPC Pharmaceutical Group (CHJTF) Financial Statements

20 Followers

CSPC Pharmaceutical Group Financial Overview

CSPC Pharmaceutical Group's market cap is currently ―. The company's EPS TTM is $0.069; its P/E ratio is 9.80; and it has a dividend yield of 5.66%. CSPC Pharmaceutical Group is scheduled to report earnings on November 19, 2024, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 13.41B¥ 10.73B¥ 11.07B¥ 8.83B¥ 7.48B
Total Assets¥ 38.84B¥ 34.74B¥ 32.85B¥ 30.07B¥ 29.17B
Total Debt¥ 682.56M¥ 94.04M¥ 154.51M¥ 316.71M¥ 289.35M
Net Debt¥ -12.73B¥ -10.63B¥ -10.91B¥ -8.51B¥ -7.20B
Total Liabilities-¥ 7.91B¥ 7.55B¥ 6.97B¥ 8.46B
Stockholders Equity¥ 28.04B¥ 25.99B¥ 24.50B¥ 22.33B¥ 19.97B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

CSPC Pharmaceutical Group Earnings and Revenue History

CSPC Pharmaceutical Group Debt to Assets

CSPC Pharmaceutical Group Cash Flow

CSPC Pharmaceutical Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis